Medyssey USA, Inc.

As a pioneer in motion preservation and innovative spine solutions, Medyssey USA, Inc., is committed to generating, developing, and commercializing intellectual property that improves the quality of patients’​ lives while designed under the mantra of simple and reproducible.

In the company’s quest to be a global market leader, Medyssey designs, develops, manufactures, and markets innovative products for the surgical treatment of spine disorders through novel instrumentation and advanced orthopedic solutions designed to improve spinal fusion rates, preservation of mobility, and optimal clinical outcomes.

Medyssey was founded in 2003 by Edward J.W. Jang, and is publicly listed on the KONEX Exchange (Korea New Exchange). With worldwide headquarters in Seoul, Korea, and North American headquarters in Chicago, Medyssey’s branch sales offices are located in China, Mexico, Brazil, and Chile. Medyssey’s technological advancement of spinal surgery is rapidly growing in Asia Pacific, the Americas, the EU, and emerging international markets, with a significant position in the U.S. market. The company’s distribution network now spans 30 countries on six continents.

Company’s Keywords:

spinal implants, instruments, biologics, custom instruments